Notice on Convening the 2025 Annual General Meeting
Filed with SSE · · 7 pages · Chinese
Zhejiang Jianfeng Group Co. Ltd. on 6ix
Earlier from Zhejiang Jianfeng
- Announcement on Progress in Repurchasing Shares through Call Auction
- Announcement on Subsidiary Obtaining a Notice of Disapproval for the Drug Marketing Authorization Application
- Earnings Preannouncement for 2025
- Announcement on Withdrawal of Clinical Trail Application for Drug Registration by Subsidiary
- Announcement on Subsidiary's Passing GMP Compliance Inspection for Drugs
Later from Zhejiang Jianfeng
- Announcement on Implementation Result of Shares Repurchase and Share Changes
- Announcement on Withdrawal of Drug Registration Application by the Subsidiary
- Report for Q1 2026
- Announcement on Subsidiary Obtaining Approval for Marketing of Chemical APIs
- Announcement on Resolutions of the 2025 Annual General Meeting
Follow Zhejiang Jianfeng into a list and get an email when it puts out news.
Follow Zhejiang Jianfeng